Umbilical cord blood transplant with pooled stem cell product shows 96% survival and no GVHD in leukemia patients

A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients ...
MedPage Today on MSN

Pooled cord blood transplants achieve near-perfect results in early trial

Disease-free survival of 96% with no severe GVHD in acute leukemia, other blood cancers ...

Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds

By Dennis Thompson HealthDay ReporterWEDNESDAY, April 29, 2026 (HealthDay News) — A new way of using umbilical cord blood — ...

New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms

New York Blood Center Enterprises’ (NYBCe) Lindsley F. Kimball Research Institute (LFKRI) today announced a scientific ...

Huntsville Hospital adds new blood exchange option for adult patients

Huntsville Hospital is expanding care options for patients with blood disorders, launching a new outpatient red blood cell ...
RFID Journal

Automating Processes to Ensure Right Blood, Right Patient, Right Time Every Time

Transfusion medicine is the branch of medicine dealing with the removal and/or transfusion of blood or blood components, including aspects related to hemovigilance. Transfusions between donors and ...